2 studies found for:    12506176 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Unknown  Cabazitaxel - PF Induction Chemotherapy
Condition: Squamous Cell Carcinoma of the Head and Neck
Interventions: Drug: Cabazitaxel 10mg/m2;   Drug: Cabazitaxel 12.5mg/m2;   Drug: Experimental: Cabazitaxel 15mg/m2;   Drug: Experimental: Cabazitaxel 17.5mg/m2;   Drug: Cabazitaxel 20mg/m2
2 Recruiting The Quarterback Trial
Condition: Squamous Cell Carcinomas
Interventions: Radiation: Reduced Dose Radiation;   Radiation: Standard Dose Radiation

Indicates status has not been verified in more than two years